Jasmiel® is an AB-rated generic oral contraceptive.
Gianvi®, Loryna™, Nikki™, and Yaz®
The Product Information Sheet features a summary of all relevant product information including Jasmiel® (drospirenone and ethinyl estradiol tablets, USP) 3 mg/0.02 mg product details, product description, NDC number, and product features.Download Now
The most frequent adverse reactions in contraception and acne clinical trials were headache/migraine, menstrual irregularities, nausea/vomiting, breast pain/tenderness, and mood changes.
Drospirenone USP (DRSP)-containing combination oral contraceptives (COCs) may be associated with a higher risk of venous thromboembolism (VTE) than COCs containing the progestin levonorgestrel or some other progestins. Before initiating use of Jasmiel in a new COC user or a woman who is switching from a contraceptive that does not contain DRSP, consider the risks and benefits of a DRSP-containing COC in light of her risk of a VTE. Known risk factors for VTE include smoking, obesity, and family history of VTE, in addition to other factors that contraindicate use of COCs.View Full Prescribing Information, Including Boxed Warning
Package Size: A Carton Containing 3 Pouches
|ANDA||1-800-331-2632 (Ext. 74591)||andanet.com||329302|
|Morris & Dickson||1-888-376-7409||morrisdickson.com||584797|
|R & S Northeast||1-800-262-7770||rsnortheast.com||024023|